Optimal design of mixed-effects PK/PD models based on differential equations
Related Experiment Video
Updated: May 26, 2026

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
Published on: January 31, 2014
Yi Wang1, Kent M Eskridge, Saralees Nadarajah
1Department of Statistics, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Abstract:
There is a vast literature on the analysis of optimal design of nonlinear mixed-effects models (NLMMs) described by ordinary differential equations (ODEs) with analytic solution. However, much less has been published on the design of trials to fit such models with nonanalytic solution. In this article, we use the "direct" method to find parameter sensitivities, which are required during the optimization of models defined as ODEs, and apply them to find D-optimal designs for various specific situations relevant to population pharmacokinetic studies using a particular model with first-order absorption and elimination. In addition, we perform two simulation studies. The first one aims to show that the criterion computed from the development of the Fisher information matrix expression is a good measure to compare and optimize population designs, thus avoiding a large number of simulations; In the second one, a sensitivity analysis with respect to parameter misspecification allows us to compare the robustness of different population designs constructed in this article.
Related Concept Videos
Pharmacokinetic–Pharmacodynamic Relationship: Model Components
Pharmacodynamic Models: Overview
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Modeling with Differential Equations
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
